Israel-based Teva Pharmaceuticals is one of five drug makers ready to produce generic versions of Cipro to help boost U.S. reserves of the antibiotic used to treat anthrax, the Jerusalem Post reported. Bayer, which has more than tripled its production of Cipro, said it was considering asking for help from manufacturers of generic drugs. Other antibiotics, including penicillin, also have been approved for anthrax treatment.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
